LL37

🧬 Core Mechanisms:

• Electrostatic Membrane Disruption: Functions as a 37-amino acid, amphipathic alpha-helical peptide derived from the C-terminal of human cathelicidin (hCAP18). It electrostatically binds to negatively charged lipid molecules on pathogen membranes, physically inserting itself to cause permeabilization, leakage, and rapid lysis.

• Endotoxin Neutralization Matrix: Directly binds to lipopolysaccharides (LPS) released by Gram-negative bacteria, neutralizing circulating endotoxins and suppressing toxic downstream TLR-4 activation cascades.

• Chemotactic Receptor Signaling: Acts as an immunomodulatory ligand that recruits neutrophils, monocytes, and T-cells to infection or injury sites via formyl peptide receptor-like 1 (FPRL1) activation.

🌟 Why Choose LL-37?

• Broad-Spectrum Antimicrobial Sovereignty: Demonstrates elite, rapid-acting destructive efficacy against Gram-positive and Gram-negative bacteria, fungi, and enveloped viruses, including highly drug-resistant strains (e.g., MRSA).

• Advanced Angiogenesis & Tissue Remodeling: Greatly accelerates wound healing kinetics by stimulating endothelial cell proliferation and tubule formation, driving rapid re-epithelialization and tissue repair.

• Biofilm Eradication Capabilities: Extensively researched for its unique capacity to penetrate, dissolve, and completely eradicate established bacterial biofilms, which are traditionally impervious to standard antibiotics.

• Precision Immune Modulation: Dynamically balances the host immune response, promoting pathogen clearance while modulating pro-inflammatory cytokine networks to prevent tissue-damaging cytokine storms.

• ---

  Note: All products are intended for laboratory and scientific research purposes only. Not FDA-approved. Not for human or animal consumption